Nirrin Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
21
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$6.7M
- Investors
-
5
Nirrin General Information
Description
Developer of a noninfectious bioprocess monitoring technology designed to deliver improved process control, faster processes, and adaptive manufacturing. The company's technology leverages innovative chemometric methods and application-specific knowledge, providing real-time analysis of glucose, lactate, Total Cell Density (TCD), Viable Cell Density (VCD), and proteins, enabling pharmaceutical companies to improve process control and develop medicines faster and more cost-effectively.
Contact Information
Website
www.nirrin.techCorporate Office
- 44 Manning Road
- Billerica, MA 01821
- United States
Corporate Office
- 44 Manning Road
- Billerica, MA 01821
- United States
Nirrin Timeline
Nirrin Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Later Stage VC (Series B) | 15-Jun-2026 | $6.7M | Completed | Generating Revenue | ||
| 6. Accelerator/Incubator | 10-Jun-2025 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 01-Jan-2025 | Completed | Generating Revenue | |||
| 4. Grant | 04-Sep-2024 | Completed | Generating Revenue | |||
| 3. Later Stage VC (Series A) | 13-Feb-2024 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 05-Oct-2021 | $8.5M | $17M | Completed | Generating Revenue | |
| 1. Seed Round | 05-May-2020 | $8.5M | $8.5M | Completed | Startup |
Nirrin Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B-2 | ||||||||
| Series B-1 | ||||||||
| Series A | 2,771,846 | $0.000100 | 8% | $7.68 | $7.68 | 1x | $7.68 | 25.73% |
| Seed | 3,000,656 | $0.000100 | 8% | $1.67 | $1.67 | 1x | $1.67 | 27.85% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Nirrin Patents
Nirrin Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260358307-A1 | Tandem hplc and nir spectroscopy system and method for monitoring bioprocesses | Pending | 12-May-2025 | ||
| WO-2026169697-A1 | In-line flow cell for monitoring bioprocesses | Pending | 07-Feb-2025 | ||
| WO-2026164951-A1 | Filtration system control based on spectroscopic analysis including sterile filtration | Pending | 30-Jan-2025 | ||
| WO-2025165726-A1 | Biologic characterization | Pending | 29-Jan-2024 | ||
| WO-2025147640-A1 | Systems and methods for wavelength and intensity referencing | Inactive | 04-Jan-2024 | G01J3/26 |
Nirrin Signals
Nirrin Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BioTools Innovator | Accelerator/Incubator | |||
| MedTech Innovator | Accelerator/Incubator | |||
| National Institutes of Health | Government | |||
| Anzu Partners | Venture Capital | Minority | ||
| Gamma Biosciences | PE-Backed Company | Minority |
Nirrin FAQs
-
When was Nirrin founded?
Nirrin was founded in 2018.
-
Where is Nirrin headquartered?
Nirrin is headquartered in Billerica, MA.
-
What is the size of Nirrin?
Nirrin has 21 total employees.
-
What industry is Nirrin in?
Nirrin’s primary industry is Biotechnology.
-
Is Nirrin a private or public company?
Nirrin is a Private company.
-
What is the current valuation of Nirrin?
The current valuation of Nirrin is .
-
What is Nirrin’s current revenue?
The current revenue for Nirrin is .
-
How much funding has Nirrin raised over time?
Nirrin has raised $28.5M.
-
Who are Nirrin’s investors?
BioTools Innovator, MedTech Innovator, National Institutes of Health, Anzu Partners, and Gamma Biosciences have invested in Nirrin.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process